Mid-Day Market Recap: VFRM, GNPX, SEEL, CETX, ATOS, DOVA

Genprex GNPX Stock News

Today has been an active day in the stock market. In case you missed it, here are the biggest stories of the day so far:

The Veritas Farms (OTCMKTS: VFRM) opportunity is growing. Not only is the company executing on big-box placements, it is expanding production abilities in a big way! Read the full story here.

Genprex (NASDAQ: GNPX) is becoming a very serious opportunity, with a leader that has a personal vendetta against cancer. Learn more here!

Seelos Therapeutics (NASDAQ: SEEL) is having a strong day in the market after acquiring a new gene therapy asset with tremendous potential. Check out the story!

Cemtrex (NASDAQ: CETX) is climbing after announcing serious growth in its contractual backlog. Here’s the scoop!

Atossa Genetics (NASDAQ: ATOS) announced positive clinical data, setting the stage for a pivotal trial and a potential entrance into a large market. Here’s what you need to know!

Finally, Dova Pharmaceuticals (NASDAQ: DOVA) announced a regulatory approval in Europe, opening the door to a serious market opportunity! Here’s the story!

CNA Finance, parent company to Alpha Stock News, has been paid to cover Genprex news.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.